RBC Bioscience

RBC Bioscience Total Assets

The Total Assets of RBC Bioscience (6848.TWO) as of Oct 21, 2026 is 763.88 M TWD. In the previous year, Total Assets was 753.79 M TWD — a change of 1.34% (higher).

Total Assets

763.88 MTWD

YoY

1.34%

Last updated:

Total Assets of RBC Bioscience is 2024 763.88 M TWD. Total Assets of RBC Bioscience was 2023 753.79 M TWD. It decreases by 1.34% higher compared to the previous year.

The RBC Bioscience Total Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Assets
Date
Total Assets
Jan 1, 2018
166.25 M TWD
Jan 1, 2019
200.95 M TWD
Jan 1, 2020
512.62 M TWD
Jan 1, 2021
847.60 M TWD
Jan 1, 2022
790.55 M TWD
Jan 1, 2023
753.79 M TWD
Jan 1, 2024
763.88 M TWD
The RBC Bioscience Total Assets history
YEARTotal AssetsYoY
763.88 MTWD+1.34%
753.79 MTWD-4.65%
790.55 MTWD-6.73%
847.60 MTWD+65.35%
512.62 MTWD+155.10%
200.95 MTWD+20.87%
166.25 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes. RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

Total Assets of RBC Bioscience is 763.88 M TWD in 2024.

Total Assets of RBC Bioscience changed from 753.79 M TWD to 763.88 M TWD, representing a 1.34% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

Total assets represent everything a company owns, including cash, inventory, property, and intangible assets. It is a key measure of a company's size and resource base.

Total Assets's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Assets's RBC Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — RBC Bioscience

All Key Metrics — RBC Bioscience